B2M and neoplasm: Additionally, since response to checkpoint blockade has been associated with expression of major histocompatibility complex class I (MHC-I) and beta-2-microglobulin (B2M) [27], we evaluated EMPD tumor cell expression of MHC-I and B2M in our cohort.